Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cosmos Health (COSM) EBITDA Margin (2016 - 2025)

Cosmos Health (COSM) has disclosed EBITDA Margin for 12 consecutive years, with 29.79% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA Margin rose 3168.0% year-over-year to 29.79%, compared with a TTM value of 29.07% through Sep 2025, up 2921.0%, and an annual FY2024 reading of 44.27%, up 270.0% over the prior year.
  • EBITDA Margin was 29.79% for Q3 2025 at Cosmos Health, down from 8.58% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 1.55% in Q1 2025 and bottomed at 303.88% in Q4 2022.
  • Average EBITDA Margin over 5 years is 49.67%, with a median of 20.95% recorded in 2024.
  • The sharpest move saw EBITDA Margin tumbled -30134bps in 2022, then surged 17892bps in 2023.
  • Year by year, EBITDA Margin stood at 2.54% in 2021, then crashed by -11873bps to 303.88% in 2022, then soared by 59bps to 124.97% in 2023, then soared by 37bps to 78.95% in 2024, then surged by 62bps to 29.79% in 2025.
  • Business Quant data shows EBITDA Margin for COSM at 29.79% in Q3 2025, 8.58% in Q2 2025, and 1.55% in Q1 2025.